CAS RN: 255706-13-9
Dabigatran Etexilate iMpurity I
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 255706-13-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
255706-13-9 / hexyl (NZ)-N-[amino-(4-aminophenyl)methylidene]carbamate
Standard CAS: 255706-13-9
Multi CAS: No
Basic Information
copy
CAS
255706-13-9 copy
Multi CAS
No copy
Molecular Formula
C14H21N3O2 copy
Molecular Weight
263.340000 copy
Exact Mass
263.163377 copy
SMILES
CCCCCCOC(=O)/N=C(/C1=CC=C(C=C1)N)\N copy
InChI
InChI=1S/C14H21N3O2/c1-2-3-4-5-10-19-14(18)17-13(16)11-6-8-12(15)9-7-11/h6-9H,2-5,10,15H2,1H3,(H2,16,17,18) copy
InChIKey
QNEVYUOYQNDIEJ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
19 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.43 copy
Rotatable bonds
6 copy
H-bond acceptors
3 copy
H-bond donors
2 copy
Molar refractivity
77.07 copy
TPSA
90.7 copy
LogP / Solubility
WLOGP
2.69 copy
MLOGP
2.38 copy
XLogP3
3.5 copy
Consensus LogP
2.86 copy
Log S (ESOL)
-3.01 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.66 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-4.33 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.42 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy